Many regions in the Northern Hemisphere experienced a slightly earlier start to their flu season, driven in some part by a novel variant of influenza A(H3N2). As our flu season also kicks off slightly earlier than usual, Elri Voigt reports on detection of this variant in South Africa and what we might expect from this year’s flu season.
COVID-19-related factors resulted in several years of lower-than-normal rates of the flu, but experts say that is now something of the past. As this year’s flu season gets under way, Elri Voigt asks several local experts what their expectations are, which flu vaccines are available this year, and whether we should be concerned about new strains of bird flu.
Respiratory Syncytial Virus (RSV) is estimated to affect 64 million people and claim around 160 000 lives around the world every year. Infants are most vulnerable and there is no effective treatment or vaccine. Tiyese Jeranji asks what we know about RSV in South Africa.
COVID began to hit South Africa badly in May 2020. Now, we are very likely beyond the worst with fewer people dying but COVID remains very infectious and rather deadly, writes Nathan Geffen and Marcus Low.
Health experts expect this year’s flu season in South Africa to be far less severe than flu seasons prior to the COVID-19 pandemic, but more severe than last year. Adele Baleta reports on the reasons for thinking this and what we know about this year’s flu vaccines and their efficacy.
While COVID-19 cases are surging in South Africa off the back of the dominant Delta variant, the flu virus has virtually vanished. Only 50 influenza cases have been detected so far this year through the country’s influenza monitoring system. Adele Baleta unpacks what is going on.
An experimental COVID-19 vaccine currently in Phase I trials being run by the University of Cape Town has a unique design that might allow it to offer better protection against current and future variants of the SARS-CoV-2 virus. Elri Voigt provides an update on the trial and unpacks the science behind this vaccine candidate.
With the COVID-19 mass vaccination rollout set to start on 17 May, many more people, for now, those older than 60 years, will receive their jabs. Elri Voigt looked into what, if anything, will change for those who have been vaccinated, and what other countries have done in this regard.
A recent global online survey suggests that more than a third of South Africans would not want a COVID-19 vaccine if and when it becomes available. Adele Baleta reports on vaccine hesitancy in South Africa.
Immunity to COVID-19 is much more interesting and much more complicated than simply something you do or do not have. Kathryn Cleary spoke to two experts about what we know about COVID-19 immunity and the implications of that for antibody testing and the development of vaccines.
Every year around 40 000 people are hospitalised with influenza in South Africa and around 11 000 die of the disease. Spotlight interviewed leading Professor in Vaccinology Shabir Madhi about the flu and its implications for the fight against COVID-19.
